Hemofiltration in heart failure

International Journal of Artificial Organs

Volumn 27, Issue 12, 2004, Pages 1070-1076

  Marenzi, Giancarlo ^a   Agostoni, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Exercise capacity; Heart failure; Hemofiltration; Lung water; Neurohormonal activation

Indexed keywords

BIOLOGICAL ORGANS; CHEMICAL ACTIVATION;

CLINICAL CONDITIONS; CONGESTIVE HEART FAILURES; EXERCISE CAPACITY; FUNCTIONAL CLASS; HEART FAILURE; HEMODYNAMIC IMPROVEMENT; HEMOFILTRATION; HYPONATREMIA; LUNG WATER; NEUROHORMONAL ACTIVATION;

CARDIOLOGY;

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROHORMONE; NORADRENALIN; POTASSIUM; SODIUM;

DISEASE SEVERITY; DIURESIS; EXERCISE; HEART FAILURE; HEMODYNAMICS; HEMOFILTRATION; HUMAN; HYPONATREMIA; LUNG CAPACITY; LUNG FLUID; LUNG FUNCTION; POTASSIUM BLOOD LEVEL; REVIEW; SIDE EFFECT; SODIUM BLOOD LEVEL; TREATMENT INDICATION; URINE VOLUME; WATER CONTENT;

EID: 12444311771     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402701210     Document Type: Review

References (38)

1. The Task Force of the European Society of Cardiology. Guidelines for the treatment of heart failure. Eur Heart J 1997; 18: 736-53.
2. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J 2002; 23:1861-6.
3. Reitsma JB, Dalstra JA, Bonsel GJ, et al. Cardiovascular disease in the Netherlands, 1975 to 1995: Decline in mortality, but increasing numbers of patients with chronic conditions. Heart 1999; 82: 52-6.
4. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-25.
5. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: Public and private health burden. Eur Heart J 1998; 19 (suppl P): S9-16.
6. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988; 77: 721-30.
7. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. N Engl J Med 1974; 291: 747-51.
8. Kramer P, Seegers A, De Vivie R, Matthaei D, Trautmann M, Scheler F. Therapeutic potential of hemofiltration. Clin Nephrol 1979; 11: 145-9.
9. Simpson IA, Rae AP, Simpson K, et al. Ultrafiltration in the management of refractory congestive heart failure. Br Heart J 1986; 55: 344-7.
10. Rimondini A, Cipolla CM, Delia Bella P, et al. Hemofiltration as a short-term treatment for refractory congestive heart failure. Am J Med 1987; 83: 43-8.
11. Marenzi GC, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni PG. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001; 38: 963-8.
12. Katz AM. Cardiomyopathy of overload: A major determinant of prognosis in congestive heart failure. N Engl J Med 1990; 322: 100-10.
13. Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP. Continuous arteriovenous hemofiltration in the critically ill patient: Clinical use and operational characteristics. Ann Intern Med 1983; 99: 455-60.
14. Marenzi GC, Grazi S, Giraldi F, et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: Effects of extracorporeal ultrafiltration. Am J Med 1993; 94: 49-56.
15. Susini G, Zucchetti MC, Bortone F, et al. Isolated ultra-filtration in cardiogenic pulmonary edema. Crit Care Med 1990; 18: 14-7.
16. Agostoni PG, Marenzi G, Pepi M, et al. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993; 21: 424-31.
17. Pepi M, Marenzi G, Agostoni PG, et al. Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: Pathophysiological correlates. Br Heart J 1993; 70: 135-40.
18. Agostoni PG, Marenzi G, Sganzerla P, et al. Lung-heart interaction as a substrate for the improvement in exercise capacity following body fluid volume depletion in moderate congestive heart failure. Am J Cardiol 1995; 76: 793-8.
19. Agostoni PG, Guazzi M, Bussotti M, Grazi M, Palermo P, Marenzi G. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol 2000; 36: 1600-4.
20. Marenzi G, Grazi M, Susini G, et al. Intra- and extravascular volumes in congestive heart failure and their redistribution following extracorporeal ultrafiltration. Cardiologia 1998; 43: 1193-200.
21. Guazzi MD, Polese A, Magrini F, Fiorentini C, Olivari MT. Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med 1975; 59: 165-70.
22. Cipolla CM, Grazi S, Rimondini A, et al. Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. Am J Cardiol 1990; 66: 987-94.
23. Guazzi MD, Agostoni PG, Perego GB, et al. The apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 1994; 72: 534-9.
24. Marenzi G, Agostoni P, Guazzi M, Lauri G, Assanelli E, Guazzi MD. The noradrenaline plasma concentration and its gradient across the lung. Eur J Clin Invest 2000; 30: 660-7.
25. Agostoni PG, Marenzi G, Guazzi M, Guazzi MD. Influence of ACE inhibition on fluid metabolism in chronic heart failure and its pathophysiologic relevance. J Cardiovasc Pharmacol Ther 1996; I: 279-86.
26. Agostoni PG, Butler J. Cardiopulmonary interaction in exercise. In: Whipp BJ, Wasserman K, eds. Exercise. Pulmonary physiology and pathophysiology. New York, Basel, Hong Kong: Dekker, 1991: 221-52.
27. Agostoni PG, Marenzi G. Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001; 96: 183-9.
28. Agostoni PG, Marenzi GC, Lauri G, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result. Am J Med 1994; 96: 191-9.
29. Canaud B, Leray-Moragues H, Garred LJ, et al. Slow isolated ultrafiltration for the treatment of congestive heart failure. Am J Kidney Dis 1996; 28 (suppl 3): S67-73.
30. Marenzi GC, Lauri G, Guazzi M, Perego GB, Agostoni PG. Ultrafiltration in moderate heart failure: Exercise oxygen uptake as a predictor of the clinical benefit. Chest 1995; 108: 94-8.
31. Assanelli E, Marenzi G, Grazi M, et al. The duration of the benefits of ultrafiltration in patients with moderate heart failure. Cardiologia 1997; 42: 95-8.
32. Agostoni PG, Marenzi G, Pepi M, et al. Changes in the physical characteristics of the lung can account for the improvement observed after ultrafiltration in patients with moderate heart failure. Cardiologia 1993; 38;4 25-9.
33. Marenzi GC, Grazi M, Susini G, et al. Intra- and extra-vascular volumes in congestive heart failure and their redistribution following extracorporeal ultrafiltration. Cardiologia 1998; 43: 1193-200.
34. Wasserman K, Zhang Y, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997; 96: 2221-7.
35. Agostoni P, Cattadori G, Guazzi M, Palermo P, Bussotti M, Marenzi G. Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure. Am Heart J 2000; 140: 24-8.
36. Janicki JS. Influence of the pericardium and ventricular interdependence on left ventricular diastolic and systolic function in patients with heart failure. Circulation 1990; 81 (suppl III): S15-20.
37. Butler J. The heart is in good hands. Circulation 1985; 67: 1163-8.
38. Butler J. The heart is not always in good hands. Chest 1990; 97: 543-60.